Table 1.
Patient characteristics by the vascular access type
| Total (N = 529) |
RC AVF (N = 264) |
BC AVF (N = 168) |
AVG (N = 97) |
P | |
|---|---|---|---|---|---|
| Age (years) | 73.6 ± 6.0 | 72.9 ± 5.8 | 74.2 ± 6.0 | 74.9 ± 6.4 | 0.007 |
| Men (N, %) | 324 (61.2) | 176 (66.7) | 92 (54.8) | 56 (57.7) | 0.087 |
| BMI (kg/m2) | 23.1 ± 3.3 | 23.5 ± 3.1 | 22.8 ± 3.5 | 22.7 ± 3.3 | 0.043 |
| SBP (mmHg) | 130.0 ± 19.5 | 131.0 ± 18.6 | 128.7 ± 18.1 | 129.2 ± 24.0 | 0.473 |
| DBP (mmHg) | 69.3 ± 10.8 | 69.7 ± 10.7 | 68.4 ± 10.3 | 70.0 ± 12.1 | 0.466 |
| Hemoglobin (g/dL) | 10.2 ± 1.4 | 10.1 ± 1.4 | 10.0 ± 1.4 | 10.5 ± 1.4 | 0.039 |
| Albumin (g/dL) | 3.5 ± 0.5 | 3.5 ± 0.5 | 3.5 ± 0.6 | 3.4 ± 0.4 | 0.126 |
| Total chol. (g/dL) | 153.4 ± 39.2 | 151.7 ± 37.5 | 153.7 ± 38.8 | 158.1 ± 44.8 | 0.428 |
| Calcium (mg/dL) | 8.5 ± 0.7 | 8.5 ± 0.7 | 8.4 ± 0.7 | 8.6 ± 0.7 | 0.222 |
| Phosphorus (mg/dL) | 4.2 ± 1.1 | 4.2 ± 1.1 | 4.1 ± 1.0 | 4.1 ± 1.2 | 0.614 |
| Glucose (mg/dL) | 123.7 ± 56.6 | 126.1 ± 57.4 | 117.2 ± 51.0 | 128.7 ± 62.8 | 0.206 |
| PTH (pg/mL) | 168.5 ± 149.1 | 170.8 ± 149.5 | 173.4 ± 142.6 | 147.0 ± 169.6 | 0.670 |
| Uric Acid (mg/dL) | 6.7 ± 2.1 | 6.8 ± 2.1 | 6.6 ± 2.4 | 6.2 ± 1.7 | 0.031 |
| hs-CRP (mg/dL) | 2.4 ± 4.3 | 2.1 ± 3.8 | 2.4 ± 4.8 | 3.1 ± 4.6 | 0.254 |
| Follow up duration (month) | 67.1 ± 44.6 | 71.0 ± 46.5 | 66.0 ± 41.3 | 58.1 ± 43.8 | 0.048 |
| Etiology of ESRD | 0.538 | ||||
| DM (N, %) | 247 (45.7) | 126 (47.7) | 74 (44.0) | 42 (43.3) | |
| HTN (N, %) | 40 (7.6) | 20 (7.6) | 13 (7.7) | 7 (7.2) | |
| GN (N, %) | 35 (6.6) | 18 (6.8) | 8 (4.8) | 9 (9.3) | |
| Others (N, %) | 61 (11.3) | 22 (8.3) | 24 (14.3) | 14 (14.4) | |
| Unknown (N, %) | 152 (28.7) | 78 (29.5) | 49 (29.2) | 25 (25.6) | |
| Comorbidities | |||||
| DM (N, %) | 304 (57.5) | 157 (59.5) | 93 (55.4) | 54 (55.7) | 0.648 |
| HTN (N, %) | 419 (79.2) | 218 (82.6) | 131 (78.0) | 70 (72.2) | 0.087 |
| CAD (N, %) | 120 (22.7) | 60 (22.7) | 32 (19.0) | 28 (28.9) | 0.184 |
| PVD (N, %) | 26 (4.9) | 9 (3.4) | 11 (6.5) | 6 (6.2) | 0.276 |
| CVD (N, %) | 106 (20.0) | 53 (20.1) | 27 (16.1) | 26 (26.8) | 0.110 |
| CHF (N, %) | 77 (14.6) | 32 (12.1) | 31 (18.5) | 14 (14.4) | 0.191 |
| Malignancy (N, %) | 98 (18.3) | 75 (17.2) | 23 (23.2) | 98 (18.3) | 0.161 |
Values are presented as number (%) or mean ± standard deviation
AVF arteriovenous fistula, AVG arteriovenous graft, BMI body mass index, BC brachiocephalic, CAD coronary artery disease, CVD cerebrovascular disease, CHF congestive heart failure, DBP diastolic blood pressure, DM diabetes mellitus, ESRD end stage renal disease, GN glomerular nephritis, hs-CRP high-sensitivity C-reactive protein, HTN hypertension, PTH parathyroid hormone, PVD peripheral vascular disease, SBP systolic blood pressure, RC radiocephalic